Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

2treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: CD19-directed CAR T cell therapy ×

CD19-directed CAR T cell therapy

This treatment is selected. Its supporting articles are shown below.

CD19-directed CAR T cell therapy1

Articles mentioning CD19-directed CAR T cell therapy

1 articles · page 1 of 1

PO:11:273 CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, for active SLE with inadequate response to glucocorticoids and at least 2 immunosuppressants: a phase 2 trial in progress

lupusscimed · abstract · 2026-03-01 · 2 matching annotations

83.7%

CD19-directed CAR T cell therapy BMS-986353 Systemic lupus erythematosus SLE glucocorticoids

…are needed. Previous reports observed that a single infusion of CD19-directed CAR T cell therapy induces deep B-cell depletion, followed by repopulation with na…

Browse treatments

CD19-directed CAR T cell therapy

Articles mentioning CD19-directed CAR T cell therapy

PO:11:273 CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, for active SLE with inadequate response to glucocorticoids and at least 2 immunosuppressants: a phase 2 trial in progress